Environmental, Social And Governance Report

Overview

The report describes HBM's 2023 focus on innovative medicines and commercialization, supported by its Harbour Therapeutics and Nona Biosciences platforms. It reports that the Board is ultimately responsible for ESG strategy, risks, goals and performance. The environmental disclosures include 2022-2026 emissions-intensity and energy-efficiency targets, along with restated 2022 GHG emissions for data consistency.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 28 March 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services